Search

Subject Palbociclib -- HCC -- CCA -- Radiosensitivity -- PP5 -- ATM

1. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response. (October 2018)

Authors:
Huang, Chao-Yuan; Hsieh, Feng-Shu; Wang, Cheng-Yi; Chen, Li-Ju; Chang, Shih-Shin; Tsai, Ming-Hsien; Hung, Man-Hsin; Kuo, Chiung-Wen; Shih, Chi-Ting; Chao, Tzu-I; Chen, Kuen-Feng
Journal:
European journal of cancer
Issue:
Volume 102(2018)
Page Start:
10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • Palbociclib -- HCC -- CCA -- Radiosensitivity -- PP5 -- ATM 1